Answer
Blood pressure monitoring is recommended when starting pramipexole in patients with severe cardiovascular disease because dopaminergic therapy carries a general risk of postural hypotension, particularly at the beginning of treatment.
Sources for this answer
- MIRAPEXIN 0.088 mg/0.18 mg/0.35 mg/0.7 mg tabletsBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 36Document updated
Sources checked